CCS

This is from a Bioshares report from the Polynovo web site

http://polynovo.com.au/wp-content/uploads/2012/06/Bioshares-524-CZD-Report-Oct-20132.pdf

"Cultured Composite Skin: The Holy Grail of Burns
Treatment, but a Much Longer Term Project
The urgency for the treatment of serious burn wounds is that the
wound needs to be sealed to prevent infection and also water
loss. Stopping the water loss also stops contraction of the wound.
To treat burns wounds, a skin graft is taken from another part of
the body. However for larger wound areas, finding sufficient donor
sites is a problem, which is amplified where thick skin grafts
need to replace deeper wounds.
A future application of this technology is the development of a
cultured composite skin (CCS) product. Here a skin graft is taken
and the skin cells are separated and grown in a bioreactor on the
NovoSorb matrix. Greenwood said that a 10cm by 10cm graft treated
in this way would be sufficient to produce enough composite skin
sheets to cover the entire body within 21 days. Preclinical proof of
principle studies in animal models have been achieved. The latest
trial results in free flap surgery with Novosorb bring this application
a step closer to a reality.

CCS has been the end goal for Dr Greenwood and success will be good news for Polynovo.
It is entirely possible that the soon to be http://www.skin.org.au/   will give us an insight as to where the CCS goal is heading.